Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$12.87 -0.34 (-2.57%)
As of: Oct 2, 2026 · 11:24 AM EDT

Arcturus Therapeutics Holdings (ARCT) Return on Assets [ROA] (2019 - 2026)

Updated

Arcturus Therapeutics Holdings' Return on Assets [ROA] came in at -40.55% for Q2 2026, down 21.78 percentage points from -18.77% a year earlier and down 9.33 percentage points from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Arcturus Therapeutics Holdings' Return on Assets [ROA] was -21.39%, down 0.46 percentage points from FY2024.

  • Return on Assets [ROA] has declined in each of the last three years, though with a five-year change of +4.22 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -20.93% in FY2024 (-14.17 pp), -6.76% in FY2023 (-8.97 pp), 2.22% in FY2022 (+49.08 pp) and -46.86% in FY2021 (-21.25 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] since Q3 2022.
  • Year-over-year, Return on Assets [ROA] has declined for five consecutive quarters, with an average year-over-year change of -11.37 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q1 2023 (a gain of 77.91 percentage points), and the weakest in Q1 2024 (a drop of 49.74 percentage points).
  • Business Quant data shows ARCT's Return on Assets [ROA] at -31.22% (Q1 2026), -23.77% (Q4 2025) and -22.55% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Arcturus Therapeutics Holdings 389.11 Mn -425.02 Mn - -40.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.55%
Mar 31, 2026 -31.22%
Dec 31, 2025 -23.77%
Sep 30, 2025 -22.55%
Jun 30, 2025 -18.77%
Mar 31, 2025 -20.17%
Dec 31, 2024 -22.64%
Sep 30, 2024 -16.49%
Jun 30, 2024 -17.81%
Mar 31, 2024 -25.31%
Dec 31, 2023 -6.70%
Sep 30, 2023 22.65%
Jun 30, 2023 18.09%
Mar 31, 2023 24.44%
Dec 31, 2022 2.83%
Sep 30, 2022 -46.22%
Jun 30, 2022 -48.39%
Mar 31, 2022 -53.47%
Dec 31, 2021 -49.04%
Sep 30, 2021 -44.44%
API Access

Arcturus Therapeutics Holdings Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ARCT&period=max&api_key=YOUR_API_KEY